Importance of echocardiography to evaluate cardio toxicity in cancer patients
Wednesday, December 7, 2011 - 05:02
in Health & Medicine
One study presented at the meeting, which is being held in Budapest, Hungary, 7 to 10 December, reports on an initiative using echocardiography to document early warning signs of adverse effects from trastuzumab (Herceptin)¹, while the other uses echocardiography to evaluate the protective role of ACE inhibitors and statins on the hearts of cancer patients².